Helix BioPharma Company (PK) (HBPCF)
USOTC
News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current HBPCF market cap is 44.82M. The company's latest EPS is CAD -0.1283 and P/E is -9.28.
| Year End July 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -7.49M | -8.62M | -9.13M | -5.87M | -6.22M |
| Net Income | -7.53M | -9.17M | -8.04M | -6.56M | -6.29M |
| Year End July 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 940k | 4.91M | 4.07M | 3.73M | 1.03M |
| Total Liabilities | 4.22M | 1.93M | 5.46M | 3.41M | 1.87M |
| Total Equity | -3.28M | 2.98M | -1.39M | 319k | -844k |
| Year End July 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -5.53M | -10.83M | -9.3M | -6.51M | -5.53M |
| Investing | -4k | 1.7M | 2.02M | N/A | -5k |
| Financing | 5.41M | 13.1M | 6.56M | 6.21M | 3.09M |
| Market Cap | 44.82M |
| Price to Earnings Ratio | -9.28 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 72.12 |
| Price to Book Ratio | -69.12 |
| Dividend Yield | - |
| Shares Outstanding | 49.02M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 29.41% |
| 52 Week High | 0.831 |
| 52 Week Low | 0.6885 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Helix BioPharma Company (PK) |
| Address |
2704, 401 bay street toronto, ontario M5H 2Y4 |
| Website | https://www.helixbiopharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
